本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2018/12/201 分钟阅读
Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations; Extension of Comment Period
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA or the Agency) is extending the comment period for the proposed rule that appeared in the Federal Register of November 15, 2018. The Agency is taking this action in response to a request for an extension to allow interested persons additional time to submit comments.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →